Increased cytokine gene expression and cognition risk associated with androgen deprivation therapy.

Our findings suggest that changes in cytokine signaling under the influence of ADT in prostate cancer patients may be linked with cognitive impairment presenting new avenues for diagnostic and therapeutic development in combating brain deficits.